[
    [
        {
            "time": "2021-08-16",
            "original_text": "最新！义翘神州上市，创A股最高发行价 | 美国对华反垄断第一案，华北制药重审获胜【最新闻0816】",
            "features": {
                "keywords": [
                    "义翘神州",
                    "A股",
                    "最高发行价",
                    "美国对华反垄断",
                    "华北制药",
                    "重审获胜"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "最新！义翘神州上市，创A股最高发行价 | 美国对华反垄断第一案，华北制药重审获胜【最新闻0816】",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业：关注CXO新秀 重点推荐皓元医药、诺泰生物等",
            "features": {
                "keywords": [
                    "医药生物",
                    "CXO",
                    "皓元医药",
                    "诺泰生物"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业：关注CXO新秀 重点推荐皓元医药、诺泰生物等",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]